Leerink initiated coverage of Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) with an Outperform rating and a price target of $25 lifting the stock price $1.71 to $19.79.
Tekmira initiated with Outperform rating
August 18, 2014 at 14:56 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|